MRes in Translational Medicine
Co-localization of p14ARF and the nucleolus protein C23
Translational Medicine allows experimental findings in the research laboratory to be converted into real benefit for the health and well-being of the patient, through the development of new innovative diagnostic tools and therapeutic approaches.
- Recognising the need for the development of a cohort of appropriately qualified scientific, medical/dental and veterinary graduates, we are offering a research intensive, student-oriented MRes in Translational Medicine
- The main objective of the MRes Programme in Translational Medicine is to provide high quality candidates with the research rigour, innovation culture and the leadership skills to be at the forefront of this translational revolution. Students will receive expert training in all aspects of translational medicine including how new experimental findings are translated into treatments for patients; the experimental steps in the process, the development of innovative solutions, management and leadership skills and an appreciation of marketing and financial aspects of translational medicine through interaction with business leaders and scientists from Biotech and Pharma
- This research intensive programme incorporates a 38 week research project in an area selected by the student in consultation with the research project co-ordinator. student selected area.
- QUB has an international reputation in translational medicine, achieved through the recognised metrics of high impact peer review publications, significant international research funding, the generation of exploitable novel intellectual property and the establishment of successful spin-out biotech companies. This ethos of innovation was recently recognised with the award of the Times Higher Education Entrepreneurial University of the Year.
Duration: The MRes is normally taken as a one year full-time programme.
Closing Date: 14 June 2013 (Late applications may be considered if places are available)
Course Content
Topics covered in core courses in first semester:
- Genomic Medicine
- Personalized Medicine
- Business Skills and Entrepreneurship
- Concept to Commercialization
- Clinical trial design in Translational Medicine
- Cancer
- Cardiovascular Medicine
- Infection and Immunity.
Research Project: 38 weeks research undertaken in one of 2 Research Centres:
- Cancer Research & Cell Biology
- Infection & Immunity
- Vision & Vascular Science
Research Dissertation: Write up of the research
Students will be expected to choose their research project in the first week of the course in the first semester. There will be opportunities to meet with the proposed supervisors of the projects during this week.At the end of the research project students will write a research dissertation on the work they have performed. It is intended that this dissertation will form the basis of a future research publication.
Entry Requirements
A minimum 2:1 honours degree (or equivalent) in a relevant biological subject is required. Evidence of equivalent professional qualifications (MBBS, BDS or BVSc) or relevant experience will be considered on an individual basis. Applicants may be required to undertake an interview.
English Language:
- an IELTS score of 6.5 with not less than 6.0 in each of the four components: Elements of Listening, Reading, Speaking and Writing and achieved within the last 2 years;
- a TOEFL score of 90+ (internet based test), taken within the last 2 years, with minimum component scores of Listening – 20, Reading – 19, Speaking – 21 and Writing – 20;
- a valid certificate of Proficiency in English grade A or B;
- a valid certificate of Advanced English grade A; or
- a first or upper class honours degree from a university in the UK, Republic of Ireland or other suitability quality assured location in a country deemed by the UK Border Agency to be a majority English speaking.
Tuition Fees
The Tuition fees for 2013/14 will published on the Student Income & Finance office once the information becomes available.
Sources of Funding
The School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast are offering a limited number of studentships to cover international fees only for a one year full time Masters commencing October 2013.
Successful candidates would be accepted for one of the following full time taught programmes:
- Masters in Public Health (MPH)
- MSc in Computational Biology
- Masters of Research in Translational Medicine
Application Process:
Candidates should make an application via the Queen's on-line application portalfor one of the courses of study: Masters in Public Health, MSc in Computational Biology or MRes in Translational Medicine For further information regarding study at Queen’s University, please refer to the International Postgraduate pages.Closing Date: 30 April 2013
The University’s also provide information on possible sources of awards which is available at the Postgraduate Centre
How to Apply
Candidates should make applications through the Universities Online Admissions portal.
Guidance is available on the University’s Prospective Student pages.
Closing Date: 15 June 2013
When applying please choose 'Medicine’ as your subject area/School.
For further advice on the application process at QUB please contact:
Admissions and Access Service
Lanyon North
Queen’s University Belfast
Belfast
BT7 1NN
Tel: +44 (0)28 9097 5081
E-mail: pg.apply@qub.ac.uk
www: www.qub.ac.uk/ado
Further Information
Professor Dennis McCance
Centre for Cancer Research and Cell Biology
Email: d.mccance@qub.ac.uk
Telephone: +00 (44) 028 9097 2763
Further Information for International Students
The University welcomes International Students each year. Candidates may find the University’s International Student Support Office website useful for finding out more about living and studying in Belfast.
Graduate Prospects
The MRes in Translational Medicine will equip students with the appropriate skills to be at the forefront of the translational medicine revolution in academia, in the hospital environment and in the biotech/pharmaceutical industries. An unrivalled exposure to the financial, management and entrepreneurial aspects of translational research will expedite their ability to exploit commercial opportunities in these innovation-rich sectors. It will also provide graduates with the skill set and academic rigor necessary to progress to a PhD in a biomedical discipline.
“The MRes course offers a solid foundation in translational research which in my experience is equally applicable to academic and industrial career paths.”
Professor Richard Kennedy MB, BCh, BAO, BSc, PhD, FRCP
Centre for Cancer Research and Cell Biology.
Medical Director, Almac Diagnostics
McClay Professor and Reader in Experimental Cancer Medicine,
Intercalated Opportunities
This Masters can be taken by students wishing to intercalate following the third year medical or dental examinations. The School are offering competitive Intercalated Scholarships (up to 10 awards) to complete this Masters programme. The Scholarships, up to the value of £6,500 each and will cover the Tuition Fees and a Bursary.
The Terms of these Scholarships, including eligibility, are as follows;
Students
- must be a registered medical or dental students at Queen’s University.
- must have successfully completed, or be due to complete, third year medical or dental examinations on the first attempt.
- must have applied online to undertake the MRes in Translational Medicine or the Masters in Public Health as intercalated degrees by 26th April 2013.
- the scholarships will be competitive and will be awarded on the basis of academic rankings used to calculate distinctions at the end of Year 2.
Once you have applied via the University's Online Admissions portal you will automatically be considered for one of the Intercalated Scholarships using the above criteria.
If you have any queries regarding these Scholarships please contact the Postgraduate and Professional Development Office by email at pgoffice.smdb@qub.ac.uk or by telephone on +44 (0) 9097 2615.
The closing date for applications from applicants wishing to be considered for a bursary is 26 April 2013.
Research Projects
Successfull applicants for the MRes in Translational Medicine will be asked to submit, as early as possible, their first three choices in order of preference. Allocation of projects will be determined at the beginning of the Academic Year.
Please refer to the links below for further information on the research projects available from each centre.Centre for Cancer Research and Cell Biology (CCRCB)
Centre for Infection and Immunity (CII)
Centre for Vision and Vascular Science (CVVS)
Centre for Public Health (CPH)